Filing Details

Accession Number:
0001179110-21-004092
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-02 15:03:50
Reporting Period:
2021-04-01
Accepted Time:
2021-04-02 15:03:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1213349 Glen Tullman C/O Teladoc Health, Inc.
2 Manhattanville Road, Suite 203
Purchase NY 10577
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-01 329,863 $5.26 605,656 No 4 M Direct
Common Stock Disposition 2021-04-01 60,148 $182.78 545,508 No 4 S Direct
Common Stock Disposition 2021-04-01 45,089 $183.78 500,419 No 4 S Direct
Common Stock Disposition 2021-04-01 44,825 $184.68 455,594 No 4 S Direct
Common Stock Disposition 2021-04-01 24,759 $185.80 430,835 No 4 S Direct
Common Stock Disposition 2021-04-01 38,977 $186.92 391,858 No 4 S Direct
Common Stock Disposition 2021-04-01 98,588 $187.85 293,270 No 4 S Direct
Common Stock Disposition 2021-04-01 17,477 $188.45 275,793 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-04-01 329,863 $0.00 329,863 $5.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-04-30 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 21,233 Indirect See footnote
Common Stock 1,812 Indirect See footnote
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020.
  2. Represents the weighted average price of transactions ranging from $182.29 to $183.28. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 8 to this Form 4.
  3. Represents the weighted average price of transactions ranging from $183.29 to $184.28.
  4. Represents the weighted average price of transactions ranging from $184.29 to $185.28.
  5. Represents the weighted average price of transactions ranging from $185.30 to $186.28.
  6. Represents the weighted average price of transactions ranging from $186.30 to $187.29.
  7. Represents the weighted average price of transactions ranging from $187.30 to $188.29.
  8. Represents the weighted average price of transactions ranging from $188.295 to $189.00.
  9. The shares are held of record by 7wire Ventures Fund, L.P. The reporting person serves as a Manager of 7wire Management, LLC, the Manager of 7wire Ventures Fund, L.P. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  10. The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  11. The option vested in full on October 30, 2020.